← Back to Search
Myc-mediated Apoptosis Is Blocked By Ectopic Expression Of Bcl-2.
A. Wagner, M. B. Small, N. Hay
Published 1993 · Biology, Medicine, Chemistry
Save to my Library
Download PDFAnalyze on Scholarcy
The product of the c-myc proto-oncogene is an important positive regulator of cell growth and proliferation. Recently, c-Myc has also been demonstrated to be a potent inducer of apoptosis when expressed in the absence of serum or growth factors. To further examine Myc-induced apoptosis, we coexpressed the proto-oncogene bcl2, which has been shown to block apoptosis in other systems, with c-myc in serum-deprived Rat 1a fibroblasts. Here we report that ectopic expression of bcl2 specifically blocks apoptosis induced by constitutive c-myc expression. Constitutive c-myc expression in serum-deprived Rat 1a cells caused a > 15-fold increase in the number of dead cells, accompanied by DNA fragmentation. However, coexpression of bcl2 with c-myc in these cells led to a 10-fold increase in the number of live cells and a significant decrease in DNA fragmentation. Thus, Bcl-2 effectively inhibits Myc-induced apoptosis in serum-deprived Rat 1a fibroblasts without blocking entry into the cell cycle. These results imply that apoptosis serves as a protective mechanism to prevent tumorigenicity elicited by deregulated Myc expression. This protective mechanism is abrogated, however, by Bcl-2 and therefore may explain the synergism between Myc and Bcl-2 observed in certain tumor cells.
This paper references
Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)
Timothy J. McDonnell (1991)
Mitochondrial protein p 26 BCL 2 reduces growth factor requirements of NIH 3 T 3 fibroblasts
S. Tanaka (1992)
Apoptosis or Programmed Cell Death
P. Waring (1991)
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
D. Hockenbery (1990)
Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells.
G. Núñez (1989)
Myc and Max proteins possess distinct transcriptional activities
L. Kretzner (1992)
Stress-resistance conferred by high level of bcl-2 alpha protein in human B lymphoblastoid cell.
Y. Tsujimoto (1989)
Cell death: the significance of apoptosis.
A. Wyllie (1980)
p53 is frequently mutated in Burkitt's lymphoma cell lines.
P. Farrell (1991)
A new technique for the assay of infectivity of human adenovirus 5 DNA.
F. Graham (1973)
Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias.
E. Alnemri (1992)
Retroviral vectors , p . 189 - 212
D. M. Glover (1987)
Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis
C. Gregory (1991)
The MYC protein activates transcription of the alpha‐prothymosin gene.
M. Eilers (1991)
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
A. Strasser (1991)
L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer
Marion M. Nau (1985)
Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240.
K. Wiman (1991)
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
D. Vaux (1988)
Complementation by BCL2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblasts.
John Calvin Reed (1990)
Apoptosis: final control point in cell biology.
G. Williams (1992)
Possible function of the c‐myc product: promotion of cellular DNA replication.
S. Iguchi-Ariga (1987)
Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer.
T. Takahashi (1990)
Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas.
Y. Shi (1992)
Expression, regulation, and chromosomal localization of the Max gene.
A. Wagner (1992)
Cell cycle analysis of p26-BCL-2 protein levels in proliferating lymphoma and leukemia cell lines.
John Calvin Reed (1992)
Flow cytometry and biochemical analysis of DNA degradation characteristic of two types of cell death
V. I. Afanas’ev (1986)
An amino-terminal c-myc domain required for neoplastic transformation activates transcription.
G. Kato (1990)
death : apoptosis and oncogenesis
G. T. Williams (1992)
Mitochondrial protein p26 BCL2 reduces growth factor requirements of NIH3T3 fibroblasts.
John Calvin Reed (1991)
DNA-bound Fos proteins activate transcription in yeast
K. Lech (1988)
Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.
C. Reddy (1992)
Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.
P. Shaw (1992)
Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product
A. Rustgi (1991)
Activation of cellular oncogenes in hemopoietic cells by chromosome translocation.
S. Cory (1986)
The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1.
G. Prendergast (1990)
Induction of apoptosis in fibroblasts by c-myc protein
G. Evan (1992)
BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense.
John Calvin Reed (1990)
This paper is referenced by
Primary explants of human uroepithelium show an unusual response to low-dose irradiation with cobalt-60 gamma rays.
C. Mothersill (1995)
Apoptosis Induced by Differentiation or Serum Deprivation in an Immortalized Central Nervous System Neuronal Cell Line
E. Eves (1996)
Apoptosis: a programmed cell death involved in ovarian and uterine physiology.
D. Vinatier (1996)
Suppression of c-Myc-Induced Apoptosis by the Epstein-Barr Virus Gene Product BHRF1
A. Fanidi (1998)
Signaling in unicellular eukaryotes.
S. T. Christensen (1998)
Human Breast Cancer Cells Proto-Oncogene Expression in Bcl-2 Mechanism Involving Estrogen Promotes Chemotherapeutic Drug Resistance by a Updated
Distinct thresholds govern Myc's biological output in vivo.
D. J. Murphy (2008)
Effects of Overexpression of C-Myc and Bcl-2 on Viability, Apoptosis and Differentiation of Dental Pulp Stem Cells
Waruna Lakmal Dissanayaka (2017)
Controllable genetic manipulation of apoptosis of cells in culture
T. Littlewood (2004)
Cell cycle and apoptosis.
B. Pucci (2000)
Apoptosis regulators and their role in tumorigenesis.
M. Zörnig (2001)
Apoptosis in B lymphocytes: The WEHI‐231 perspective
A. Gottschalk (1995)
Apoptosis and signal transduction: clues to a molecular mechanism.
S. Lee (1993)
Blood Cell Biochemistry
A. Whetton (1996)
Counteracting inhibition of apoptosis by c-Myc, Bcl-2, and c-FLIP: A multifaceted approach to inducing cell death
L. Sheng (2010)
Induction of multiple PCR-SSCPE mobility shifts in p53 exons in cultures of normal human urothelium exposed to low-dose gamma-radiation.
S. Colucci (1997)
p53-dependent apoptosis pathways.
Y. Shen (2001)
Apoptosis and predisposition to oral cancer.
P. Polverini (1999)
Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc.
V. Polunovsky (1996)
Human Parvovirus B19 Nonstructural (NS1) Protein Induces Apoptosis in Erythroid Lineage Cells
S. Moffatt (1998)
Cell cycle checkpoints and apoptosis: potential for improving radiation therapy.
R. Muschel (1997)
Transforming growth factor‐β2 induces apoptosis of murine T cell clones without down‐regulating bcl‐2 mRNA expression
M. Weller (1994)
c-Myc induction of programmed cell death may contribute to carcinogenesis
C. Wang (2011)
The Integration of Signalling Pathways in Mammalian Cells
G. Evan (1997)
Biochemical Changes during Growth and Regression of Pregnancy-Dependent Mammary Tumors of GR/A Mice
Y. Goto (1995)
Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: growth factors protect against c-myc-independent apoptosis.
A. Hague (1997)
Differential sensitivity of murine myeloid FDC-P1 cells and apoptosis resistant mutant(s) to anticancer drugs.
N. Singh (2001)
Cell Cycle Control
M. Pagano (1998)
Defining a role for c-Myc in breast tumorigenesis
S. Nass (2004)
Treatment of ME180 Cells with Interferon-γ Causes Apoptosis as a Result of Tryptophan Starvation
Kouacou V. Konan (1996)
Stable transfection of CHO cells with the c-myc gene results in increased proliferation rates, reduces serum dependency, and induces anchorage independence
Vasiliki Ifandi (2004)
p53 in tumor progression: life, death, and everything.
M. Mowat (1998)See more